---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-24-002393"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:28:31.360289+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Entera Bio shareholders approve all 8 proposals at 2024 annual meeting

## Summary
- Elected Miranda Toledano and Yonatan Malca to three-year board terms with ~99% of votes cast.
- Approved one-time CEO compensation grant for Miranda Toledano (14,365,894 for, 544,357 against).
- Approved amendment to 2018 Equity Incentive Plan, increasing shares by 1,788,515 (14,131,640 for).
- Ratified Kesselman & Kesselman (PwC) as independent auditors for FY2024 with overwhelming support.
- Advisory vote on executive compensation passed; the most frequent frequency vote was 'one year'.

## SEC filing metadata
- accession: 0001178913-24-002393
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891324002393/0001178913-24-002393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891324002393/zk2431764.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-24-002393
- JSON: https://secwatch.observer/filing/0001178913-24-002393.json
- Plain text: https://secwatch.observer/filing/0001178913-24-002393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.